Barrington Research Reiterates Outperform Rating for Henry Schein (NASDAQ:HSIC)

by · The Cerbat Gem

Henry Schein (NASDAQ:HSIC – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Barrington Research in a research note issued to investors on Friday, Benzinga reports. They presently have a $82.00 price target on the stock. Barrington Research’s target price indicates a potential upside of 15.25% from the company’s previous close.

HSIC has been the topic of several other reports. Robert W. Baird dropped their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. decreased their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Evercore ISI decreased their price target on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a report on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, UBS Group decreased their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $77.10.

Read Our Latest Stock Report on Henry Schein

Henry Schein Stock Performance

Shares of HSIC opened at $71.15 on Friday. The firm’s 50 day moving average is $69.89 and its 200-day moving average is $70.35. The stock has a market capitalization of $9.11 billion, a P/E ratio of 24.04, a P/E/G ratio of 1.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein has a 12-month low of $60.01 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s quarterly revenue was up .0% compared to the same quarter last year. During the same period last year, the firm posted $1.31 earnings per share. Equities research analysts anticipate that Henry Schein will post 4.75 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Large investors have recently modified their holdings of the company. KBC Group NV boosted its holdings in shares of Henry Schein by 163.5% during the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock worth $39,518,000 after buying an additional 323,901 shares during the period. Everett Harris & Co. CA boosted its holdings in shares of Henry Schein by 13.9% during the 1st quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock worth $9,006,000 after buying an additional 14,580 shares during the period. UniSuper Management Pty Ltd boosted its holdings in shares of Henry Schein by 611.8% during the 1st quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after buying an additional 11,771 shares during the period. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Henry Schein by 64.2% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock worth $3,138,000 after buying an additional 16,241 shares during the period. Finally, Artisan Partners Limited Partnership raised its stake in Henry Schein by 9.5% during the 4th quarter. Artisan Partners Limited Partnership now owns 292,911 shares of the company’s stock valued at $22,176,000 after purchasing an additional 25,378 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles